Vanguard Global Advisers’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109K Hold
37,699
﹤0.01% 2744
2026
Q1
$73.9K Buy
+37,699
New +$88.4K ﹤0.01% 2851

Other funds holding GDRX

Vanguard Global Advisers's GDRX Position: Q2 2026 in Review

Vanguard Global Advisers held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 37,699 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2744.

Vanguard Global Advisers first reported a position in GDRX in Q1 2026 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Vanguard Global Advisers held 37,699 shares of GoodRx Holdings worth $109K as of Q2 2026.
  • Vanguard Global Advisers left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2744 holding.
  • Vanguard Global Advisers first reported a position in GoodRx Holdings in Q1 2026 and has held it in 2 quarters since.
  • 160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.